Sept. 1, 2023, 2:57 p.m. |

Latest stories for ZDNET in Artificial-Intelligence www.zdnet.com

Recursion Pharmaceuticals uses machine learning to develop drugs with Bayer and Genentech. CEO Chris Gibson thinks proceeding with that work outweighs any risks a moratorium might prevent.

ai research ceo chris drugs genentech machine machine learning pharma pharmaceuticals recursion recursion pharmaceuticals research risks work

Staff Research Scientist, AI/ML

@ Chan Zuckerberg Initiative | Redwood City, CA

Senior Machine Learning Engineer, Science

@ Chan Zuckerberg Initiative | Redwood City, California

AI Innovator in Healthcare

@ GAIA AG | Remote, Germany

Senior Machine Learning Engineer

@ Kintsugi | remote

Staff Machine Learning Engineer (Tech Lead)

@ Kintsugi | Remote

R_00029290 Lead Data Modeler – Remote

@ University at Buffalo | Austin, TX